Low birthweight · pregnant women
Potent/very potent topical corticosteroids may leads to higher low birth weight compared with no topical corticosteroids (low certainty).
1 finding from 1 review
RR 1.58
47651 participants
Low
Preterm birth · pregnant women
Potent/very potent topical corticosteroids may leads to higher preterm delivery compared with no topical corticosteroids (low certainty).
1 finding from 1 review
RR 1.05
47651 participants
Low
Foetal death · pregnant women
Potent/very potent topical corticosteroids may leads to higher foetal death compared with no topical corticosteroids (low certainty).
1 finding from 1 review
RR 1.14
37086 participants
Low
Low Apgar score · pregnant women
Potent/very potent topical corticosteroids may leads to higher low Apgar score compared with no topical corticosteroids (low certainty).
1 finding from 1 review
RR 1.03
7514 participants
Low
Fatigue relief ( · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Adverse events · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Serious adverse events · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
QoL · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Fatigue relief ( · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Adverse events · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Serious adverse events · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Quality of life ( · adults with advanced cancer and cancer‐related fatigue
1 finding from 1 review
Incidence of coronary artery abnormalities · children diagnosed with Kawasaki disease
Corticosteroids probably leads to lower incidence of coronary artery abnormalities compared with no corticosteroid use (moderate certainty).
1 finding from 1 review
Mortality (all‐cause) · children diagnosed with Kawasaki disease
1 finding from 1 review
Duration of clinical symptoms: fever and rash (days) · children diagnosed with Kawasaki disease
1 finding from 1 review
Time for laboratory parameters to normalise: CRP, ESR (days) Duration: N/A · children diagnosed with Kawasaki disease
1 finding from 1 review
Length of hospital stay · children diagnosed with Kawasaki disease
1 finding from 1 review
Longer term (> 1 year after disease onset) coronary morbidity (non‐aneurysmal) · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain resolution · patients with sore throat
Corticosteroids leads to higher complete resolution of pain at 24 hours compared with placebo (high certainty).
2 findings from 1 review
Time to initial pain relief (minutes) · patients with sore throat
1 finding from 1 review